Metraipolis › archive › dc_16c8146df7ca

Berubicin Substituted for Cytarabine in a MATRix-Based Regimen for Isolated Central Nervous System Lymphoma: A Five-Patient Case Series from the BER-PUM Study — Europe PMC PMID:42782903

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42782903
DOI
10.3390/curroncol33090557
License (as archived)
solo-consultazione
Archived
2026-10-09T23:54:47.385Z
SHA-256 of the archived text
9c1f722b7233319354544ea6049c0ff8f3982eb9224db4f981ad2698ba3001f3
Stable URL of this page
https://metraipolis.com/documento/dc_16c8146df7ca

How to cite

Berubicin Substituted for Cytarabine in a MATRix-Based Regimen for Isolated Central Nervous System Lymphoma: A Five-Patient Case Series from the BER-PUM Study — Europe PMC PMID:42782903 — Europe PMC (en), https://europepmc.org/article/MED/42782903 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_16c8146df7ca (Metraipolis archive dc_16c8146df7ca, sha256 9c1f722b7233319354544ea6049c0ff8f3982eb9224db4f981ad2698ba3001f3)
BibTeX
@misc{dc16c8146df7ca,
  title = {Berubicin Substituted for Cytarabine in a MATRix-Based Regimen for Isolated Central Nervous System Lymphoma: A Five-Patient Case Series from the BER-PUM Study — Europe PMC PMID:42782903},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42782903},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_16c8146df7ca; sha256 9c1f722b7233319354544ea6049c0ff8f3982eb9224db4f981ad2698ba3001f3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42782903. Agents can read the archived copy with the MCP tool read_document.